This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: **Innovator Spotlight: Kangwen L Lin**
Introduction
Kangwen L Lin is an accomplished inventor based in Fremont, CA, with a remarkable portfolio of four patents. His work primarily focuses on the development of novel formulations and compounds, showcasing his expertise in the field of pharmaceutical sciences.
Latest Patents
Among his most notable inventions are his contributions to the formulations of benzimidazolyl pyridyl ethers. One significant patent describes salts of benzimidazolyl pyridyl ethers, specifically detailing the compound {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine and its formulations. This innovative work encompasses combinations with surfactants and methods for preparing these compositions. Another patent focuses on various formulations of benzimidazolyl pyridyl ethers, which may include a mixture of hydrophilic and lipophilic solvents and emulsifiers, presenting both liquid and solid embodiments.
Career Highlights
Kangwen L Lin currently works at Novartis AG, a prominent company in the pharmaceutical sector. His dedication to research and development has resulted in advancements that potentially enhance therapeutic options available to patients. His contributions are a testament to his commitment to innovation in medicine.
Collaborations
Throughout his career, Lin has collaborated with fellow professionals, including Ahmad Hashash and Augustus O Okhamafe. These partnerships reflect a collaborative spirit within the innovative community, driving forward the development of new and effective pharmaceutical solutions.
Conclusion
Kangwen L Lin's expertise and inventive spirit exemplify the dynamic nature of the pharmaceutical industry. With a solid foundation of patents and an ongoing commitment to innovation, he continues to contribute valuable advancements that may improve health outcomes. His work serves as an inspiration to aspiring inventors and professionals in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile